SCHEMBL30814733

SCHEMBL30814733

N#CCc1cc(F)ccc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 5/20 0.40
MPO P05164 1/20 0.34
SLC6A4 P31645 1/20 0.34
DPP4 P27487 1/20 0.33
PKM P14618 1/20 0.32
MAPT P10636 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HTT P42858 1/20 0.32
CYP2A6 P11509 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
HPGD P15428 1/20 0.31
FFAR1 O14842 1/20 0.31
TSPO P30536 1/20 0.31
DRD3 P35462 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL534703 1.00 CSNK2A1 (0.40) CSNK2A1MPOSLC6A4DPP4PKM
SCHEMBL160087 0.84 CSNK2A1 (0.40) CSNK2A1MPOSLC6A4PKMMAPT
SCHEMBL31248059 0.81 MPO (0.42) MPOSLC6A4DPP4PKMMAPT
SCHEMBL29618975 0.79 PSEN1 (0.40) MPOSLC6A4DPP4ALDH1A1CYP2A6
SCHEMBL1020440 0.79 PSEN1 (0.40) MPOSLC6A4DPP4ALDH1A1CYP2A6
SCHEMBL28856582 0.79 CSNK2A1 (0.51) CSNK2A1PKMALDH1A1CYP2A6MAOB
SCHEMBL669166 0.77 CSNK2A1 (0.33) CSNK2A1MPOSLC6A4MAOAMAOB
SCHEMBL957181 0.76 SLC6A4 (0.40) MPOSLC6A4MAPTALDH1A1HTT
SCHEMBL3067018 0.76 ESR1 (0.40) MPOSLC6A4MAPTALDH1A1TDP1
SCHEMBL22904292 0.76 MAOA (0.41) MPOSLC6A4DPP4MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025125688-A2 NOVEL COMPOUNDS FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2025-06-19 WO disclosed
WO-2024046221-A1 EGFR INHIBITORS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2024-03-07 WO disclosed